Press Release
Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale
Mesh Bio, a Singapore-based health deep tech startup transforming chronic disease management through predictive analytics, announced today that it has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. This round…